Focused Wealth Management’s Guardant Health GH Stock Holding History

Focused Wealth Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50	Closed	-$1.35K	–	491
2023 Q4	$1.35K	Hold	50	–	–	﹤0.01%	824
2023 Q3	$1.48K	Hold	50	–	–	﹤0.01%	802
2023 Q2	$1.79K	Hold	50	–	–	﹤0.01%	817
2023 Q1	$1.17K	Hold	50	–	–	﹤0.01%	853
2022 Q4	$1.36K	Hold	50	–	–	﹤0.01%	827
2022 Q3	$3K	Hold	50	–	–	﹤0.01%	703
2022 Q2	$2K	Sell	50 -10	-17%	-$495	﹤0.01%	729
2022 Q1	$4K	Hold	60	–	–	﹤0.01%	706
2021 Q4	$6K	Buy	60 +15	+33%	+$1.55K	﹤0.01%	664
2021 Q3	$6K	Buy	45 +10	+29%	+$1.19K	﹤0.01%	683
2021 Q2	$4K	Sell	35 -5	-13%	-$673	﹤0.01%	752
2021 Q1	$6K	Sell	40 -10	-20%	-$1.51K	﹤0.01%	678
2020 Q4	$6K	Buy	+50	New	+$5.75K	﹤0.01%	630
2019 Q3	–	Sell	-1,475	Closed	-$127K	–	733
2019 Q2	$127K	Buy	+1,475	New	+$113K	0.03%	207

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Focused Wealth Management's GH Position: Q1 2024 in Review

Focused Wealth Management sold out of Guardant Health (GH) in Q1 2024, closing a stake of 50 shares — an estimated $1.35K sold.

Focused Wealth Management first reported a position in GH in Q2 2019 and held it in 14 quarters. The position peaked at $127K in Q2 2019. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

Focused Wealth Management reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
Focused Wealth Management sold 50 Guardant Health shares in Q1 2024, an estimated $1.35K.
Focused Wealth Management first reported a position in Guardant Health in Q2 2019 and held it in 14 quarters.
Focused Wealth Management's Guardant Health position peaked at $127K in Q2 2019.
258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.